- Home
- HUIZ vs KALA Comparison
HUIZ vs KALA Comparison
Compare HUIZ & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- KALA
- Stock Information
- Founded
- HUIZ 2006
- KALA 2009
- Country
- HUIZ China
- KALA United States
- Employees
- HUIZ N/A
- KALA N/A
- Industry
- HUIZ Specialty Insurers
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- KALA Health Care
- Exchange
- HUIZ Nasdaq
- KALA Nasdaq
- Market Cap
- HUIZ 25.3M
- KALA 26.2M
- IPO Year
- HUIZ 2020
- KALA 2017
- Fundamental
- Price
- HUIZ $2.59
- KALA $12.19
- Analyst Decision
- HUIZ Hold
- KALA Strong Buy
- Analyst Count
- HUIZ 1
- KALA 2
- Target Price
- HUIZ $2.30
- KALA $13.50
- AVG Volume (30 Days)
- HUIZ 32.3K
- KALA 150.1K
- Earning Date
- HUIZ 09-12-2025
- KALA 08-08-2025
- Dividend Yield
- HUIZ N/A
- KALA N/A
- EPS Growth
- HUIZ N/A
- KALA N/A
- EPS
- HUIZ N/A
- KALA N/A
- Revenue
- HUIZ $168,454,627.00
- KALA N/A
- Revenue This Year
- HUIZ $11.94
- KALA N/A
- Revenue Next Year
- HUIZ $8.15
- KALA N/A
- P/E Ratio
- HUIZ N/A
- KALA N/A
- Revenue Growth
- HUIZ 1.28
- KALA N/A
- 52 Week Low
- HUIZ $1.50
- KALA $2.92
- 52 Week High
- HUIZ $10.58
- KALA $12.91
- Technical
- Relative Strength Index (RSI)
- HUIZ 57.05
- KALA 81.29
- Support Level
- HUIZ $2.25
- KALA $8.50
- Resistance Level
- HUIZ $2.60
- KALA $8.75
- Average True Range (ATR)
- HUIZ 0.19
- KALA 0.86
- MACD
- HUIZ 0.01
- KALA 0.30
- Stochastic Oscillator
- HUIZ 84.23
- KALA 86.98
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.